Cronos Group Inc.
CRON · NASDAQ
Bulios Fair Price
$2.14
33.1% downside
Current Price
$3.2
According to Bulios Fair Price, CRON is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Cronos Group Inc. (CRON) is a Canadian company operating in the legal cannabis industry and cannabis-based products. The company specializes in cultivating and producing cannabis for medical and recreational purposes. Cronos Group has a global presence and operates in several countries where cannabis and its products are legal. The company offers a wide range of products, including dried cannabis, oils, tinctures, vaporizer cartridges, and other consumer products based on cannabis. Cronos Group Inc. closely monitors regulations and laws related to legal cannabis in various countries and strives to maintain the highest standards of quality and safety for its products. Shares of Cronos Group Inc. (CRON) can present an interesting investment opportunity for investors following the growing market of legal cannabis and its products.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Michael Ryan Gorenstein
Employees
610
Headquarters
Stayner
Upcoming events
Earnings
Upcoming earnings report